A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

Clinical trial NCT05665530 · COMPLETED

Trial details

NCT number: NCT05665530
Sponsor: Prelude Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Mantle Cell Lymphoma (MCL)Richter's Syndrome T-cell Lymphoma Diffuse Large B-cell Lymphoma (DLBCL)Marginal Zone Lymphoma Myeloid Malignancies Acute Myeloid Leukemia (AML)Chronic Myelomonocytic Leukemia (CMML)Myelodysplastic Syndrome (MDS)MDS/Myeloproliferative Neoplasm (MPN) Overlap Syndrome

Start date: 2023-09-12
Primary completion: 2025-06-12
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.